title: Commentary on Willegaignon et al.: outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure.
authors.affiliation: Department of Radiation Oncology and Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90025-5014, USA. csmarcus@ucla.edu
authors.forename: Carol S
authors.initials: CS
authors.lastname: Marcus
mesh_terms: D000553:Ambulatory Care / Q000331:legislation & jurisprudence* / Q000379:methods*; D004781:Environmental Exposure / Q000009:adverse effects / Q000331:legislation & jurisprudence; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D009683:Nuclear Medicine / Q000331:legislation & jurisprudence* / Q000379:methods*; D011879:Radiotherapy Dosage; D012449:Safety / Q000331:legislation & jurisprudence*; D013964:Thyroid Neoplasms / Q000532:radiotherapy*
chemical_list: D007457:Iodine Radioisotopes